We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+4.26%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$5.92B
AUM Growth
+$1.77B
Cap. Flow
+$1.61B
Cap. Flow %
27.24%
Top 10 Hldgs %
29.35%
Holding
6,215
New
374
Increased
3,547
Reduced
1,424
Closed
549

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$87.5M
2
AAPL icon
Apple
AAPL
+$68.6M
3
AMZN icon
Amazon
AMZN
+$62.8M
4
META icon
Meta Platforms (Facebook)
META
+$41.4M
5
AMD icon
Advanced Micro Devices
AMD
+$39.4M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$158M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$70.2M
3
QQQ icon
Invesco QQQ Trust
QQQ
+$34.4M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$33.9M
5
DIA icon
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
+$22.9M

Sector Composition

Rank Sector Weight
1 Technology 29.49%
2 Consumer Discretionary 9.8%
3 Financials 9.15%
4 Healthcare 9.12%
5 Communication Services 8.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LNSR icon
4651
LENSAR
LNSR
$74.3M
$5.8K ﹤0.01%
1,289
-1,584
-55% -$6.1K
UAMY icon
4652
United States Antimony
UAMY
$994M
$5.79K ﹤0.01%
17,234
-8,916
-34% -$2.49K
ATIP
4653
DELISTED
ATI Physical Therapy, Inc.
ATIP
$5.79K ﹤0.01%
+1,295
New +$5.98K
MNPR icon
4654
Monopar Therapeutics
MNPR
$776M
$5.78K ﹤0.01%
1,584
+13
+0.8% +$46
CVIIU
4655
DELISTED
Churchill Capital Corp VII Units
CVIIU
$5.77K ﹤0.01%
535
– –
SOAR icon
4656
Volato Group
SOAR
$9.41M
$5.75K ﹤0.01%
+393
New +$16K
INTZ
4657
Intrusion
INTZ
$17.1M
$5.74K ﹤0.01%
5,221
+4,807
+1,161% +$8.73K
AYTU icon
4658
AYTU BioPharma
AYTU
$25.5M
$5.73K ﹤0.01%
1,962
-1,064
-35% -$3.21K
ARC
4659
DELISTED
ARC Document Solutions, Inc.
ARC
$5.72K ﹤0.01%
+2,167
New +$5.82K
BGMS
4660
Bio Green Med Solution Inc
BGMS
$4.96M
$5.69K ﹤0.01%
15
-2
-12% -$961
TXMD icon
4661
TherapeuticsMD
TXMD
$24.1M
$5.69K ﹤0.01%
3,534
+1,897
+116% +$3.83K
AAMC
4662
DELISTED
Altisource Asset Management Corp
AAMC
$5.69K ﹤0.01%
2,963
-38
-1% -$107
BBU
4663
DELISTED
Brookfield Business Partners
BBU
$5.67K ﹤0.01%
301
-2,180
-88% -$41.8K
VINO
4664
DELISTED
Gaucho Group Holdings, Inc. Common Stock
VINO
$5.66K ﹤0.01%
878
+495
+129% +$2.85K
LINK icon
4665
Interlink Electronics
LINK
$80.6M
$5.65K ﹤0.01%
2,102
-3,469
-62% -$12.2K
TRT
4666
Trio-Tech International
TRT
$107M
$5.63K ﹤0.01%
1,850
+660
+55% +$2.12K
DRIO icon
4667
DarioHealth
DRIO
$73.7M
$5.63K ﹤0.01%
236
+16
+7% +$453
RKDA icon
4668
Arcadia Biosciences
RKDA
$1.38M
$5.62K ﹤0.01%
1,783
-1,991
-53% -$5.04K
HBM icon
4669
Hudbay
HBM
$12.3B
$5.61K ﹤0.01%
621
-3,221
-84% -$28K
VEU icon
4670
Vanguard FTSE All-World ex-US ETF
VEU
$70B
$5.57K ﹤0.01%
95
-2,125
-96% -$125K
DMAC icon
4671
DiaMedica Therapeutics
DMAC
$355M
$5.57K ﹤0.01%
1,888
-808
-30% -$2.22K
MNTS icon
4672
Momentus
MNTS
$88.9M
$5.54K ﹤0.01%
41
-17
-29% -$2.22K
IRD
4673
Opus Genetics
IRD
$307M
$5.5K ﹤0.01%
3,592
-3,784
-51% -$6.54K
BKTI icon
4674
BK Technologies
BKTI
$282M
$5.48K ﹤0.01%
428
-320
-43% -$4.37K
RPID icon
4675
Rapid Micro Biosystems
RPID
$86.7M
$5.47K ﹤0.01%
8,296
+2,749
+50% +$2.35K
185 186
187
188 189

Similar funds

HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
DWM
Destination Wealth Management Walnut Creek, California $3.85B AUM 13% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
AC
Anther Capital Hong Kong $3.83B AUM
IP
Interval Partners New York $3.82B AUM 27.38% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return

Tower Research Capital (TRC)'s Q2 2024 Portfolio in Review

As of Q2 2024, Tower Research Capital (TRC) held 6,215 positions worth $5.92B, up 43% from $4.15B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Tower Research Capital (TRC) deployed $1.61B of net new capital in Q2 2024, opening 374 new positions and adding to 3,547 existing holdings. Its largest new stake was State Street Financial Select Sector SPDR ETF: 480,124 shares worth $19.7M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $158M trimmed.

  • Tower Research Capital (TRC)'s largest Q2 2024 buy was State Street Financial Select Sector SPDR ETF: 480,124 shares worth $19.7M.
  • Tower Research Capital (TRC) added most to Microsoft in Q2 2024, an estimated $87.5M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $158M.
  • Tower Research Capital (TRC) fully exited iShares Core S&P Mid-Cap ETF in Q2 2024, selling an estimated $18.3M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 29% of its $5.92B portfolio in Q2 2024.
  • Tower Research Capital (TRC) opened 374 new positions and closed 549 in Q2 2024.
  • Tower Research Capital (TRC)'s portfolio value rose 43% quarter-over-quarter to $5.92B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2024, filed 13 Aug 2024.